Effect of Topical Brimonidine on Post Cataract Surgery Corneal Edema
Corneal Edema, Visual Acuity
About this trial
This is an interventional treatment trial for Corneal Edema focused on measuring corneal edema, postoperative corneal edema, central corneal thickness, visual acuity, postoperative, brimonidine, timolol, cataract surgery
Eligibility Criteria
Inclusion Criteria:
- 1 day after uneventful cataract surgery
- corneal edema (grade 2 to 3)
Exclusion Criteria:
- glaucoma
- higher than normal intraocular pressure (>23 mm Hg)
- known sensitivity or contra indication to brimonidine
- known sensitivity or contra indication to timolol
- pre operative corneal or anterior segment disease
- intraoperative complications
- major ocular pathology other than corneal that reduced vision (retinal degeneration, optic neuropathy etc.)
- pregnant women
- children
Sites / Locations
- Rabin medical center ophthalmology deparment
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Active Comparator
No Intervention
brimonidine
2 tmolol
3
50 patients receiving Brimonidine Tartrate drops in the operated eye: 1 drop X2 a day for 1 month. they will also be administered the usual medications after cataract surgery (corticosteroids and antibiotics drops)
50 patients receiving timolol maleate 0.5% drops in the operated eye 1 drop X2 a day for 1 month. they will also be administered the usual medications after cataract surgery (corticosteroids and antibiotics drops)
50 patients will not receive any additional drug to the usual medications after cataract surgery (corticosteroids and antibiotics drops)